
Certifications
Hematology
American Board of Internal Medicine
Education
MD, New York University School of Medicine
Residency, Internal Medicine
Montreal General HospitalResidency, Internal Medicine
Stanford University School of MedicineFellowship, Hematology
Mount Sinai Hospital
Clinical Trials
- Use of Histone Deacetylase Inhibitors to Treat Myelofibrosis
- LBH589, A novel Histone Deacetylase Inhibito/ PMF PostPV
- A Phase 1/2 Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 Inhibitor AZD1480 Administered Orally to Patients with Primary Myelofibrosis (PMF) and Post-Polycythemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF)
- CEP-701 in Adults with Myelofibrosis
- Phase II Study of Bevacizumab (Avastin) in Myelofibrosis
Industry Relationships
Physicians and scientists on the faculty of Mount Sinai School of Medicine often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Hoffman during 2011 and/or 2012. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- AllCells, LLC; Bristol-Myers Squibb; Forest Research Institute Inc (Forest Laboratories, Inc); Incyte Corporation
Scientific Advisory Board:
- AllCells, LLC
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://www.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Tisch Cancer Institute; Atran Berg Laboratory Building
1428 Madison Avenue, E Level, Box 1079
New York, NY 10029
Fax: 212-876-5276

1190 Fifth Avenue
Ruttenberg Treatment Center
New York, NY 10029



